OpenURL Connection Search

Select item for more details and to access through your institution.

Real-world efficacy and safety of anlotinib as third- or further-line treatment in refractory small cell lung cancer.
Published in:
Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 10, p. 2661, doi. 10.1007/s00432-021-03848-4
By:
- Gao, Xuetian;
- Peng, Ling;
- Zhang, Li;
- Huang, Kai;
- Yi, Cuihua;
- Li, Bei;
- Meng, Xue;
- Li, Jisheng
Publication type:
Article
Herpes Virus Entry Mediator in Human Corneal Epithelial Cells Modulates the Production of Inflammatory Cytokines in Response to HSV Type 1 Challenge.
Published in:
Ophthalmic Research, 2015, v. 54, n. 3, p. 128, doi. 10.1159/000437209
By:
- Guo, Hui;
- Pang, Kunpeng;
- Wei, Yan;
- Yi, Cuihua;
- Wu, Xinyi
Publication type:
Article
Association of microRNA polymorphisms with gastric cancer risk in the North Chinese Han population.
Published in:
Journal of Cancer Research & Therapeutics, 2022, v. 18, n. 2, p. 581, doi. 10.4103/jcrt.jcrt_74_21
By:
- Xin, Qian;
- Shan, Shan;
- Ding, E;
- Jin, Mingxin;
- Li, Bei;
- Li, Jiangxia;
- Liu, Qiji;
- Yi, Cuihua;
- Li, Jisheng
Publication type:
Article
Thymidylate synthase expression and prognosis in colorectal cancer: a meta-analysis of colorectal cancer survival data.
Published in:
International Journal of Biological Markers, 2012, v. 27, n. 3, p. e203, doi. 10.5301/JBM.2012.9584
By:
- Yao Chen;
- Cuihua Yi;
- Lian Liu;
- Bei Li;
- Yawei Wang;
- Xiuwen Wang
Publication type:
Article
Distribution of uridine diphosphate glucuronosyltransferase 1A polymorphisms and their role in irinotecan-induced toxicity in patients with cancer.
Published in:
Oncology Letters, 2017, v. 14, n. 5, p. 5743, doi. 10.3892/ol.2017.6933
By:
- YANG WANG;
- CUIHUA YI;
- YAWEI WANG;
- HUI LI;
- BEI LI;
- DAN WANG;
- JINTONG DU;
- LIAN LIU;
- XIUWEN WANG
Publication type:
Article
Could S-1-based non-platinum doublet chemotherapy be a new option as a second-line treatment for advanced nonsmall cell lung cancer patients? A multicenter retrospective study.
Published in:
Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1089234
By:
- Xiangling Wang;
- Ting Wang;
- Yunxia Chu;
- Jie Liu;
- Cuihua Yi;
- Xuejun Yu;
- Yonggang Wang;
- Tianying Zheng;
- Fangli Cao;
- Linli Qu;
- Bo Yu;
- Huayong Liu;
- Fei Ding;
- Shuang Wang;
- Xiangbo Wang;
- Jing Hao;
- Xiuwen Wang
Publication type:
Article
Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study.
Published in:
Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1444707
By:
- Hongxin Li;
- Wen Zhao;
- Caiyun Chang;
- Tiantian Xuan;
- Chengjun Wang;
- Rongyu Zhang;
- Chuang Yang;
- Jian Wang;
- Cuihua Yi;
- Xiuwen Wang;
- Shuwen Yu;
- Jisheng Li
Publication type:
Article
Co-Occurring Alterations of ERBB2 Exon 20 Insertion in Non-Small Cell Lung Cancer (NSCLC) and the Potential Indicator of Response to Afatinib.
Published in:
Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00729
By:
- Yuan, Bo;
- Zhao, Jun;
- Zhou, Chengzhi;
- Wang, Xiumei;
- Zhu, Bo;
- Zhuo, Minglei;
- Dong, Xilin;
- Feng, Jiemei;
- Yi, Cuihua;
- Yang, Yunpeng;
- Zhang, Hua;
- Zhou, Wangyan;
- Chen, Zhengtang;
- Yang, Sheng;
- Ai, Xinghao;
- Chen, Kehe;
- Cui, Xuefan;
- Liu, Difa;
- Shi, Chunmei;
- Wu, Wei
Publication type:
Article

Found: 8